Katrine Bosley

Shares of Editas Medicine Inc (NASDAQ: EDIT) tumbled 20 percent Tuesday after the CEO of the genome editing company announced her resignation. Editas said Katrine Bosley will step down as president, CEO and board member while board member Cynthia Collins will run the company as interim CEO. The...

Twitter Inc (NYSE: TWTR) can be an extremely useful and tradable tool for investors, but only if you follow the right people. Here’s a look at 11 biotech and pharmaceutical company CEOs that have the potential for market-moving tweets. 1. Brent Saunders - @brentlsaunders Saunders is...